Type of Cancer
Skin and Soft Tissue
Phase
Division (Location)
Study ID
NCT#
Brief Description
RANDOMIZED PHASE II STUDY OF NIVOLUMAB WITH OR WITHOUT IPILIMUMAB IN PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.